Associated Papers
UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1.
Yang X et al.
Science Advances, 2025
Genetic landscape and prognosis of conjunctival melanoma in Chinese patients.
Shi H et al.
The British Journal of Ophthalmology, 2024
38383070 (PubMed )
Supplement: bjo-2023-324306supp002.pdf
Saturation genome editing of BAP1 functionally classifies somatic and germline variants.
Waters AJ et al.
Nature Genetics, 2024
38969833 (PubMed )
Supplement: 41588_2024_1799_MOESM19_ESM.xlsx › extended_data_fig_7_a
Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis.
van Poppelen NM et al.
International Journal of Molecular Sciences, 2021
34071371 (PubMed )
Supplement: ijms-22-05784-s001.zip › ijms-1219237-supplementary.pdf
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.
de Unamuno Bustos B et al.
Scientific Reports, 2017
28356599 (PubMed )
Supplement: 41598_2017_606_MOESM2_ESM.xls › Table_S1
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013
Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials.
Lovly CM et al.
Plos One, 2012
Select a paper to view details